These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 7466042)

  • 1. [Physiopathology of hyperlipidemias, practical approach (author's transl)].
    Ducobu J
    Rev Med Brux; 1980 Oct; 1(8):503-9. PubMed ID: 7466042
    [No Abstract]   [Full Text] [Related]  

  • 2. [Lipoproteins and hyperlipoproteinemias].
    Weisweiler P; Schwandt P
    Fortschr Med; 1980 Mar; 98(9):313-6. PubMed ID: 7372258
    [No Abstract]   [Full Text] [Related]  

  • 3. Hyperlipoproteinemias, recognition, classification, clinical features and treatment.
    Herrmann GR
    Rev Esp Cardiol; 1971; 24(2):153-70. PubMed ID: 5137098
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipoproteinemias: experience of out-patient treatment of 112 patients (author's transl)].
    Arteaga A; Maiz A; Lathrop R
    Rev Med Chil; 1981 Oct; 109(10):945-51. PubMed ID: 7344018
    [No Abstract]   [Full Text] [Related]  

  • 5. [Incidence of hyperlipoproteinemias, their classification and influencing through diet during a course of spa treatment. II. Clinical part].
    Sachlová M; Hofman J; Zwetschke O
    Vnitr Lek; 1974 Jan; 20(1):15-27. PubMed ID: 4847012
    [No Abstract]   [Full Text] [Related]  

  • 6. [Clofibrate in diabetes insipidus (author's transl)].
    Oster P; Raetzer H; Schlierf G
    Dtsch Med Wochenschr; 1974 Jul; 99(30):1564-5. PubMed ID: 4367876
    [No Abstract]   [Full Text] [Related]  

  • 7. Hyperlipoproteinemias: pathogenesis, diagnosis, and treatment.
    Stacpoole PW
    Compr Ther; 1983 Mar; 9(3):27-39. PubMed ID: 6839688
    [No Abstract]   [Full Text] [Related]  

  • 8. [Biguanide therapy of primary hyperlipoproteinemias type IIb, 3 and IV as monotherapy and combined with clofibrate].
    Koschinsky T; Vogelberg KH; Gries FA
    Verh Dtsch Ges Inn Med; 1973; 79():1294-6. PubMed ID: 4795174
    [No Abstract]   [Full Text] [Related]  

  • 9. Lipoprotein metabolism and the etiology of hyperlipidemia.
    Gotto AM
    Hosp Pract (Off Ed); 1988 Jun; 23 Suppl 1():4-13. PubMed ID: 3134384
    [No Abstract]   [Full Text] [Related]  

  • 10. [Drug therapy of hypertriglyceridemias (author's transl)].
    Gries FA
    MMW Munch Med Wochenschr; 1980 Mar; 122(13):471-3. PubMed ID: 6769019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Classification and etiology of hyperlipoproteinemia].
    Kita T
    Nihon Naika Gakkai Zasshi; 1991 Jul; 80(7):1141-7. PubMed ID: 1919230
    [No Abstract]   [Full Text] [Related]  

  • 12. [Effect of clofibrate therapy on serum lipids and lipoproteins].
    Romics L; Szondy E; Gerö S
    Orv Hetil; 1980 Feb; 121(6):321-3. PubMed ID: 7366989
    [No Abstract]   [Full Text] [Related]  

  • 13. [Effect of treatment on lipoprotein metabolism. II. How to treat?].
    Cybulska B
    Przegl Lek; 1987; 44(6):520-4. PubMed ID: 3685440
    [No Abstract]   [Full Text] [Related]  

  • 14. Pathogenesis and treatment of lipoprotein disorders.
    Stacpoole P
    Compr Ther; 1989 Apr; 15(4):28-44. PubMed ID: 2650981
    [No Abstract]   [Full Text] [Related]  

  • 15. [Physiopathology and clinical aspects of lipid metabolism disorders. Clinical aspects and therapy of primary hyperlipoproteinemias].
    Haller H; Hanefeld M; Leonhardt W
    Dtsch Gesundheitsw; 1971 Sep; 26(37):1721-6. PubMed ID: 5122707
    [No Abstract]   [Full Text] [Related]  

  • 16. [Effect of treatment on lipoprotein metabolism. I. Why and when to treat?].
    Cybulska B
    Przegl Lek; 1987; 44(6):516-9. PubMed ID: 3685439
    [No Abstract]   [Full Text] [Related]  

  • 17. [HDL-2000: A consensus. HDL--a neglected lipoprotein].
    Sinzinger H; Hoppichler F; Kritz H; Laimer H; Schmid P; Silberbauer K; Toplak H;
    Wien Klin Wochenschr; 2001 Mar; 113(5-6):212-4. PubMed ID: 11293953
    [No Abstract]   [Full Text] [Related]  

  • 18. [Serum lipid changes in familial hyperlipoproteinaemia during spa treatment (author's transl].
    Sadílek L; Krízek V; Stĕpánek P; Sobra J; Traurig J
    Cas Lek Cesk; 1981 Sep; 120(36):1090-5. PubMed ID: 7273078
    [No Abstract]   [Full Text] [Related]  

  • 19. [Behavior of lipoproteins in xanthomatoses].
    Fanta D; Formanek I; Niebauer G
    Wien Klin Wochenschr; 1971 May; 83(18):313-8. PubMed ID: 5577410
    [No Abstract]   [Full Text] [Related]  

  • 20. Step-care approach to hyperlipidemia: guidelines for clinicians.
    Cantwell JD
    J Med Assoc Ga; 1984 Feb; 73(2):107-11. PubMed ID: 6707544
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.